Literature DB >> 34172087

Correction to: Design considerations of an IL13Rα2 antibody-drug conjugate for difuse intrinsic pontine glioma.

Xiaolei Lian1, Dina Kats1, Samuel Rasmussen1, Leah R Martin1, Anju Karki1, Charles Keller2, Noah E Berlow3.   

Abstract

Entities:  

Year:  2021        PMID: 34172087      PMCID: PMC8235579          DOI: 10.1186/s40478-021-01210-w

Source DB:  PubMed          Journal:  Acta Neuropathol Commun        ISSN: 2051-5960            Impact factor:   7.801


× No keyword cloud information.

Correction to: acta neuropathol commun 9, 88 (2021) https://doi.org/10.1186/s40478-021-01184-9

In the original publication [1] there was an incorrect funding acknowledgement. In this correction article the correct and incorrect funding acknowledgement are published. The original article has been updated. Incorrect funding This study was funded by a grant from the Matthew Larson Foundation for Pediatric Brain Tumors, as well as donations in honor of Calee, Caleb, Nicole, and Andrew. Correct funding This study was funded by a grant from the Matthew Larson Foundation for Pediatric Brain Tumors, as well as donations in honor of Caleb, Caleb, Nicole, and Andrew.
  1 in total

1.  Design considerations of an IL13Rα2 antibody-drug conjugate for diffuse intrinsic pontine glioma.

Authors:  Xiaolei Lian; Dina Kats; Samuel Rasmussen; Leah R Martin; Anju Karki; Charles Keller; Noah E Berlow
Journal:  Acta Neuropathol Commun       Date:  2021-05-17       Impact factor: 7.801

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.